The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 11th 2025
States have expanded access to over-the-counter ivermectin, raising concerns among health experts about safety, misinformation, and self-medication risks.
FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children At Increased Risk
Published: July 10th 2025 | Updated: July 10th 2025mRNA-1273, marketed as Spikevax by Moderna, is now fully approved for individuals aged 6 months through 64 years with high-risk features for severe COVID-19.
Read More
Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies
July 9th 2025The 2025 National Lipid Association (NLA) Scientific Sessions highlighted a strategic shift toward early, aggressive cardiometabolic intervention, underscoring the vital role of pharmacists in implementing emerging therapies and optimizing cardiovascular risk reduction.
Read More
McKesson ideaShare 2025 Set to Empower Pharmacy Professionals in Nashville
July 9th 2025Packed with CE sessions, interactive learning, expert insights, and a vibrant expo floor, McKesson ideaShare 2025 aims to equip independent pharmacists with the tools and strategies to elevate patient care and drive pharmacy innovation.
Read More
Hospitalized Adults With Community-Acquired Pneumonia Suffer Significant Morbidity Post Discharge
July 4th 2025Six months following discharge from the hospital, adults who battled community-acquired pneumonia were at heightened risk of losing the ability to perform activities and experiencing poor quality of life.
Read More
Navigating Rilonacept Therapy: Dose Adjustments, Discontinuation, and Patient Support Strategies
Pharmacists and clinicians collaborate to carefully manage rilonacept therapy.
Watch
Thimerosal Reenters Public Debate as ACIP Scrutinizes Use in Influenza Vaccines
June 27th 2025With the Advisory Committee on Immunization Practices recommending that adults receive thimerosal-free influenza vaccines, the preservative that was phased out of most childhood vaccines in 2001 has reentered the public eye.
Read More